Possible Benefits of Metformin for Lung Cancer Still Unknown

Tyrosine kinase inhibitors (TKI) or monoclonal antibodies (mAb) for the Treatment of NRG1 and, Potentially, NRG2 Fusion–Positive Malignancies

Vemurafenib Alone and Combination for Lung Cancer: A Conversation with Marcelo V. Negrao, MD

Premonitions About Lung Cancer for the Next Decade 

Pyrotinib: A Potential New Anti-HER2 Therapy for Lung Cancer

The New WHO Classification of Lung Tumors

Lung Cancer Biomarker Testing Patterns Varied Widely in Japan

Liquid Biopsy: The Key Weapon for Real-Time Monitoring of Patients With NSCLC 

PD-L1 Blockade Reinvigorates Dendritic Cells for Antitumor Immunity

Research’s Race to Stop a Pandemic

Impactful Multidisciplinary Care Not Out of Reach in Community Settings

CT Findings of COVID-19 Pneumonia and Mimicking Diseases in Patients With Lung Cancer